For this reason, we performed in vitro studies in colon cancer cells (SW-620) treated with RE to confirm and validate the specific effect of RE on decreasing the expression levels of JAK1, NFE2L2, CHKA, and BMP2 genes. Here, NFE2L2 is linked to colonic neoplasm.